Danish researchers (Hans Hasselbalch et al) are discussing the increased risk/likelihood of AD (Alzheimers Disease) for MPN patients, perhaps due to inflammation. There is no evidence yet, but it is considered likely.
Worth investigating is if medication can help / reduce the risk of AD. Perhaps a combination treatment of Interferon (INF) / Hydrea (Hydroxyurea), combined with possibly JAKAVI (Ruxolitinib)
I’ve attached the full PDF here for my own purpose: